<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font18 { font-size : 18; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font30">with </span>
   <span class="font29">and </span>
   <span class="font25">for </span>
   <span class="font24">patients </span>
   <span class="font22">liver </span>
   <span class="font18">COVID- </span>
   <span class="font16">disease </span>
   <span class="font15">risk </span>
   <span class="font15">should </span>
   <span class="font14">are </span>
   <span class="font14">{background </span>
   <span class="font14">care </span>
   <span class="font14">severe </span>
   <span class="font14">chronic </span>
   <span class="font13">not </span>
   <span class="font13">margin </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">these </span>
   <span class="font13">treatment </span>
   <span class="font13">{border-style </span>
   <span class="font12">coronavirus </span>
   <span class="font12">may </span>
   <span class="font12">px;} </span>
   <span class="font12">that </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">also </span>
   <span class="font12">after </span>
   <span class="font12">clinical </span>
   <span class="font12">course </span>
   <span class="font12">from </span>
   <span class="font12">local </span>
   <span class="font12">ahead </span>
   <span class="font12">been </span>
   <span class="font12">cirrhosis </span>
   <span class="font12">have </span>
   <span class="font12">print] </span>
   <span class="font11">The </span>
   <span class="font11">drugs </span>
   <span class="font11">infection </span>
   <span class="font11">transplantation </span>
   <span class="font11">Patients </span>
   <span class="font11">virus </span>
   <span class="font11">COVID-. </span>
   <span class="font11">[], </span>
   <span class="font11">acute </span>
   <span class="font11">considerations </span>
   <span class="font11">viral </span>
   <span class="font11">•In </span>
   <span class="font11">antiviral </span>
   <span class="font11">associated </span>
   <span class="font11">but </span>
   <span class="font11">case </span>
   <span class="font11">drug </span>
   <span class="font11">efficacy </span>
   <span class="font11">has </span>
   <span class="font11">hepatitis </span>
   <span class="font11">syndrome </span>
   <span class="font11">will </span>
   <span class="font11">COVID-: </span>
   <span class="font11">However, </span>
   <span class="font11">against </span>
   <span class="font11">can </span>
   <span class="font11">considered </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">individual </span>
   <span class="font11">might </span>
   <span class="font11">other </span>
   <span class="font11">px; </span>
   <span class="font11">respiratory </span>
   <span class="font11">such </span>
   <span class="font11">trial </span>
   <span class="font11">vitro </span>
   <span class="font11">{font-family </span>
   <span class="font11">ALT </span>
   <span class="font11">RNA </span>
   <span class="font11">addition, </span>
   <span class="font11">advanced </span>
   <span class="font11">available </span>
   <span class="font11">data </span>
   <span class="font11">decompensated </span>
   <span class="font11">diseases </span>
   <span class="font11">exposure </span>
   <span class="font11">font-size </span>
   <span class="font11">including </span>
   <span class="font11">management </span>
   <span class="font11">medical </span>
   <span class="font11">more </span>
   <span class="font11">patient </span>
   <span class="font11">provide </span>
   <span class="font11">reports </span>
   <span class="font11">some </span>
   <span class="font11">surveillance </span>
   <span class="font11">under </span>
   <span class="font11">which </span>
   <span class="font10">COVID-, </span>
   <span class="font10">HCC </span>
   <span class="font10">This </span>
   <span class="font10">Thus, </span>
   <span class="font10">currently </span>
   <span class="font10">double; </span>
   <span class="font10">experience </span>
   <span class="font10">factors </span>
   <span class="font10">healthcare </span>
   <span class="font10">increased </span>
   <span class="font10">influenza </span>
   <span class="font10">outpatient </span>
   <span class="font10">patients. </span>
   <span class="font10">potential </span>
   <span class="font10">providers </span>
   <span class="font10">receptor </span>
   <span class="font10">regards </span>
   <span class="font10">remains </span>
   <span class="font10">require </span>
   <span class="font10">specialised </span>
   <span class="font10">testing </span>
   <span class="font10">wherever </span>
   <span class="font10">without </span>
   <span class="font10">(e.g. </span>
   <span class="font10">General </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">avoid </span>
   <span class="font10">based </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">centres </span>
   <span class="font10">chloroquine </span>
   <span class="font10">cohorts </span>
   <span class="font10">consider </span>
   <span class="font10">disease, </span>
   <span class="font10">during </span>
   <span class="font10">early </span>
   <span class="font10">elevations </span>
   <span class="font10">health </span>
   <span class="font10">immune </span>
   <span class="font10">importance </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">inpatient </span>
   <span class="font10">non-alcoholic </span>
   <span class="font10">novel </span>
   <span class="font10">pandemic </span>
   <span class="font10">performed </span>
   <span class="font10">prevent </span>
   <span class="font10">procedures </span>
   <span class="font10">reactivation </span>
   <span class="font10">recommend </span>
   <span class="font10">recommendations </span>
   <span class="font10">several </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">therapy </span>
   <span class="font10">there </span>
   <span class="font10">those </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">•No </span>
   <span class="font10">ACE </span>
   <span class="font10">Available </span>
   <span class="font10">Drug </span>
   <span class="font10">Engl </span>
   <span class="font10">Hepatol </span>
   <span class="font10">March </span>
   <span class="font10">Med[Epub </span>
   <span class="font10">Table </span>
   <span class="font10">These </span>
   <span class="font10">[Accessed </span>
   <span class="font10">according </span>
   <span class="font10">acute-on-chronic </span>
   <span class="font10">additional </span>
   <span class="font10">admission </span>
   <span class="font10">admission. </span>
   <span class="font10">amount </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">approved </span>
   <span class="font10">biopsy </span>
   <span class="font10">characteristics </span>
   <span class="font10">cirrhosis, </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">critically </span>
   <span class="font10">cytokine </span>
   <span class="font10">damage </span>
   <span class="font10">deferred </span>
   <span class="font10">diagnosis </span>
   <span class="font10">diagnostic </span>
   <span class="font10">dissemination </span>
   <span class="font10">due </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">enzyme </span>
   <span class="font10">failure </span>
   <span class="font10">from: </span>
   <span class="font10">general </span>
   <span class="font10">guidelines </span>
   <span class="font10">hepatic </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">infections </span>
   <span class="font10">information </span>
   <span class="font10">inhibitor </span>
   <span class="font10">injury </span>
   <span class="font10">laboratory </span>
   <span class="font10">levels </span>
   <span class="font10">limit </span>
   <span class="font10">model </span>
   <span class="font10">most </span>
   <span class="font10">nosocomial </span>
   <span class="font10">observations </span>
   <span class="font10">only </span>
   <span class="font10">patients, </span>
   <span class="font10">phone </span>
   <span class="font10">pneumonia </span>
   <span class="font10">possible </span>
   <span class="font10">presence </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently </span>
   <span class="font10">reduced </span>
   <span class="font10">required </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
   <span class="font10">trials </span>
   <span class="font10">unknown </span>
   <span class="font10">used </span>
   <span class="font10">whether </span>
   <span class="font10">who </span>
   <span class="font10">•Consider </span>
   <span class="font10">•Patients </span>
  </p>
 </body>
</html>
